Literature DB >> 24045077

Inter-modality relationship constrained multi-modality multi-task feature selection for Alzheimer's Disease and mild cognitive impairment identification.

Feng Liu1, Chong-Yaw Wee, Huafu Chen, Dinggang Shen.   

Abstract

Previous studies have demonstrated that the use of integrated information from multi-modalities could significantly improve diagnosis of Alzheimer's Disease (AD). However, feature selection, which is one of the most important steps in classification, is typically performed separately for each modality, which ignores the potentially strong inter-modality relationship within each subject. Recent emergence of multi-task learning approach makes the joint feature selection from different modalities possible. However, joint feature selection may unfortunately overlook different yet complementary information conveyed by different modalities. We propose a novel multi-task feature selection method to preserve the complementary inter-modality information. Specifically, we treat feature selection from each modality as a separate task and further impose a constraint for preserving the inter-modality relationship, besides separately enforcing the sparseness of the selected features from each modality. After feature selection, a multi-kernel support vector machine (SVM) is further used to integrate the selected features from each modality for classification. Our method is evaluated using the baseline PET and MRI images of subjects obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Our method achieves a good performance, with an accuracy of 94.37% and an area under the ROC curve (AUC) of 0.9724 for AD identification, and also an accuracy of 78.80% and an AUC of 0.8284 for mild cognitive impairment (MCI) identification. Moreover, the proposed method achieves an accuracy of 67.83% and an AUC of 0.6957 for separating between MCI converters and MCI non-converters (to AD). These performances demonstrate the superiority of the proposed method over the state-of-the-art classification methods.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's Disease; Inter-modality relationship; Mild cognitive impairment; Multi-kernel support vector machine; Multi-task feature selection

Mesh:

Year:  2013        PMID: 24045077      PMCID: PMC3849328          DOI: 10.1016/j.neuroimage.2013.09.015

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  38 in total

1.  The neural basis of intrusions in free recall and cued recall: a PET study in Alzheimer's disease.

Authors:  Béatrice Desgranges; Jean-Claude Baron; Bénédicte Giffard; Gaël Chételat; Catherine Lalevée; Fausto Viader; Vincent de la Sayette; Francis Eustache
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

2.  A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry.

Authors:  G B Karas; E J Burton; S A R B Rombouts; R A van Schijndel; J T O'Brien; P h Scheltens; I G McKeith; D Williams; C Ballard; F Barkhof
Journal:  Neuroimage       Date:  2003-04       Impact factor: 6.556

3.  Brain metabolic effects of Neotrofin in patients with Alzheimer's disease.

Authors:  Steven G Potkin; Gustavo Alva; David Keator; Danilo Carreon; Kirsten Fleming; James H Fallon
Journal:  Brain Res       Date:  2002-09-27       Impact factor: 3.252

Review 4.  Cerebral blood flow and metabolic abnormalities in Alzheimer's disease.

Authors:  H Matsuda
Journal:  Ann Nucl Med       Date:  2001-04       Impact factor: 2.668

5.  Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.

Authors:  Kazunari Ishii; Hiroki Sasaki; Atsushi K Kono; Naokazu Miyamoto; Tetsuya Fukuda; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-31       Impact factor: 9.236

6.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data.

Authors:  J G Sled; A P Zijdenbos; A C Evans
Journal:  IEEE Trans Med Imaging       Date:  1998-02       Impact factor: 10.048

Review 7.  Voxelwise meta-analysis of gray matter anomalies in Alzheimer's disease and mild cognitive impairment using anatomic likelihood estimation.

Authors:  Jing Yang; PingLei Pan; Wei Song; Rui Huang; JianPeng Li; Ke Chen; QiYong Gong; JianGuo Zhong; HaiChun Shi; HuiFang Shang
Journal:  J Neurol Sci       Date:  2012-03-03       Impact factor: 3.181

8.  Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population.

Authors:  Chris Hinrichs; Vikas Singh; Guofan Xu; Sterling C Johnson
Journal:  Neuroimage       Date:  2010-12-10       Impact factor: 6.556

9.  Multivariate examination of brain abnormality using both structural and functional MRI.

Authors:  Yong Fan; Hengyi Rao; Hallam Hurt; Joan Giannetta; Marc Korczykowski; David Shera; Brian B Avants; James C Gee; Jiongjiong Wang; Dinggang Shen
Journal:  Neuroimage       Date:  2007-04-19       Impact factor: 6.556

10.  Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

Authors:  K B Walhovd; A M Fjell; J Brewer; L K McEvoy; C Fennema-Notestine; D J Hagler; R G Jennings; D Karow; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

View more
  67 in total

1.  Matrix-Similarity Based Loss Function and Feature Selection for Alzheimer's Disease Diagnosis.

Authors:  Xiaofeng Zhu; Heung-Il Suk; Dinggang Shen
Journal:  Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit       Date:  2014-06

2.  Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease.

Authors:  Tingting Ye; Chen Zu; Biao Jie; Dinggang Shen; Daoqiang Zhang
Journal:  Brain Imaging Behav       Date:  2016-09       Impact factor: 3.978

3.  Identification of Alzheimer's disease and mild cognitive impairment using multimodal sparse hierarchical extreme learning machine.

Authors:  Jongin Kim; Boreom Lee
Journal:  Hum Brain Mapp       Date:  2018-05-07       Impact factor: 5.038

4.  Combining Disrupted and Discriminative Topological Properties of Functional Connectivity Networks as Neuroimaging Biomarkers for Accurate Diagnosis of Early Tourette Syndrome Children.

Authors:  Hongwei Wen; Yue Liu; Islem Rekik; Shengpei Wang; Zhiqiang Chen; Jishui Zhang; Yue Zhang; Yun Peng; Huiguang He
Journal:  Mol Neurobiol       Date:  2017-05-06       Impact factor: 5.590

5.  Fusion of ULS Group Constrained High- and Low-Order Sparse Functional Connectivity Networks for MCI Classification.

Authors:  Yang Li; Jingyu Liu; Ziwen Peng; Can Sheng; Minjeong Kim; Pew-Thian Yap; Chong-Yaw Wee; Dinggang Shen
Journal:  Neuroinformatics       Date:  2020-01

6.  Identification of minimal hepatic encephalopathy based on dynamic functional connectivity.

Authors:  Yue Cheng; Gaoyan Zhang; Xiaodong Zhang; Yuexuan Li; Jingli Li; Jiamin Zhou; Lixiang Huang; Shuangshuang Xie; Wen Shen
Journal:  Brain Imaging Behav       Date:  2021-03-23       Impact factor: 3.978

7.  Multi-Domain Transfer Learning for Early Diagnosis of Alzheimer's Disease.

Authors:  Bo Cheng; Mingxia Liu; Dinggang Shen; Zuoyong Li; Daoqiang Zhang
Journal:  Neuroinformatics       Date:  2017-04

8.  Manifold regularized multitask feature learning for multimodality disease classification.

Authors:  Biao Jie; Daoqiang Zhang; Bo Cheng; Dinggang Shen
Journal:  Hum Brain Mapp       Date:  2014-10-03       Impact factor: 5.038

9.  Multi-task feature selection via supervised canonical graph matching for diagnosis of autism spectrum disorder.

Authors:  Liye Wang; Chong-Yaw Wee; Xiaoying Tang; Pew-Thian Yap; Dinggang Shen
Journal:  Brain Imaging Behav       Date:  2016-03       Impact factor: 3.978

10.  Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment.

Authors:  Chen Zu; Biao Jie; Mingxia Liu; Songcan Chen; Dinggang Shen; Daoqiang Zhang
Journal:  Brain Imaging Behav       Date:  2016-12       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.